501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | Lupus Science and Medicine |
| _version_ | 1828115564036358144 |
|---|---|
| author | Michelle Petri John Conklin Anca Askanase Wei Tang Yevgeniya Gartshteyn Roberta Vezza Alexander Vasileios Kyttaris Anja Kammesheidt |
| author_facet | Michelle Petri John Conklin Anca Askanase Wei Tang Yevgeniya Gartshteyn Roberta Vezza Alexander Vasileios Kyttaris Anja Kammesheidt |
| author_sort | Michelle Petri |
| collection | DOAJ |
| first_indexed | 2024-04-11T12:42:25Z |
| format | Article |
| id | doaj.art-c053cadfe36a46afb9d2ddb050548950 |
| institution | Directory Open Access Journal |
| issn | 2053-8790 |
| language | English |
| last_indexed | 2024-04-11T12:42:25Z |
| publishDate | 2022-12-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Lupus Science and Medicine |
| spelling | doaj.art-c053cadfe36a46afb9d2ddb0505489502022-12-22T04:23:27ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-12-019Suppl 310.1136/lupus-2022-lupus21century.18501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosusMichelle Petri0John Conklin1Anca Askanase2Wei Tang3Yevgeniya Gartshteyn4Roberta Vezza Alexander5Vasileios Kyttaris6Anja Kammesheidt7Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USAExagen Inc, Vista, California, USA2 Rheumatology, Columbia University College of Physicians and Surgeons, New York, New York, USAEmergency Department, Pengzhou Traditional Chinese Medical Hospital, Sichuan, ChinaDepartment of Rheumatology, Columbia University Irving Medical Center, New York, New York, USAExagen Inc, Vista, California, USA4Beth Israel Deaconess Medical Center, Boston, MA2Exagen Inc., Vista, CA |
| spellingShingle | Michelle Petri John Conklin Anca Askanase Wei Tang Yevgeniya Gartshteyn Roberta Vezza Alexander Vasileios Kyttaris Anja Kammesheidt 501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus Lupus Science and Medicine |
| title | 501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus |
| title_full | 501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus |
| title_fullStr | 501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus |
| title_full_unstemmed | 501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus |
| title_short | 501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus |
| title_sort | 501 role of platelet bound complement activation product pc4d in predicting risk of future thrombotic events in systemic lupus erythematosus |
| work_keys_str_mv | AT michellepetri 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus AT johnconklin 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus AT ancaaskanase 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus AT weitang 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus AT yevgeniyagartshteyn 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus AT robertavezzaalexander 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus AT vasileioskyttaris 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus AT anjakammesheidt 501roleofplateletboundcomplementactivationproductpc4dinpredictingriskoffuturethromboticeventsinsystemiclupuserythematosus |